Back
Sarepta Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
30
SRPT
Sarepta Therapeutics
Last Price:
110.51
Seasonality Move:
16.38%
Sell
46
VRTX
Vertex Pharmaceuticals
Last Price:
450.38
Seasonality Move:
11.1%
Sell
30
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $110.50. The Score for SRPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $450.37. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $110.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $450.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.89 | Sell |
| Relative Strength Index (14 RSI): | 37.25 | Sell |
| Chaikin Money Flow: | 63193 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (112 - 129.78) | Sell |
| Bollinger Bands (100): | (119.81 - 143.67) | Sell |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.97 | Sell |
| Relative Strength Index (14 RSI): | 37.76 | Sell |
| Chaikin Money Flow: | 44374 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (462.09 - 494.97) | Sell |
| Bollinger Bands (100): | (465.11 - 492.19) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.13 | Buy |
| 20-day SMA: | 118.88 | Sell |
| 50-day SMA: | 122.22 | Sell |
| 200-day SMA: | 130.09 | Sell |
| 8-day EMA: | 110.76 | Sell |
| 20-day EMA: | 116.02 | Sell |
| 50-day EMA: | 122.15 | Sell |
| 200-day EMA: | 126.16 | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 468.86 | Sell |
| 20-day SMA: | 479.26 | Sell |
| 50-day SMA: | 474.44 | Sell |
| 200-day SMA: | 453.81 | Sell |
| 8-day EMA: | 465.05 | Sell |
| 20-day EMA: | 474.27 | Sell |
| 50-day EMA: | 475.71 | Sell |
| 200-day EMA: | 452.67 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.54 per share, and an increase next year of $18.39 per share.
Sarepta Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||